Latest news
AstraZeneca Pharma India reports robust growth in Q1 FY2026–27 - Business UpturnBusiness Upturn · Mon, 10 Aug 2026 19:16:05 GMTAstraZeneca Pharma India Q1 Revenue Rises 30% To ₹682.8 Crore - BW Healthcare WorldBW Healthcare World · Mon, 10 Aug 2026 14:21:42 GMTAstraZeneca Pharma India Q1 Profit Drops 32% to Rs 37.93 Cr - Rediff MoneyWizRediff MoneyWiz · Mon, 10 Aug 2026 10:30:49 GMTAstraZeneca Expands India Market Access for Enhertu with Additional Breast Cancer Indication - NAVLIN DAILYNAVLIN DAILY · Mon, 10 Aug 2026 09:31:53 GMTAstraZeneca India gets CDSCO nod for Enhertu in new breast cancer indication - WhalesbookWhalesbook · Sat, 08 Aug 2026 07:24:51 GMTAstraZeneca Pharma India secures CDSCO approval for Enhertu in new breast cancer use - scanx.tradescanx.trade · Sat, 08 Aug 2026 06:31:12 GMTCDSCO clears expanded use of AstraZeneca’s cancer blockbuster Enhertu - ET PharmaET Pharma · Wed, 29 Jul 2026 07:00:00 GMTAstraZeneca Pharma India gets CDSCO nod to import and distribute breast cancer treatment drug - CNBC TV18CNBC TV18 · Tue, 28 Jul 2026 11:17:19 GMT